Celcuity (CELC) Current Assets (2016 - 2025)
Celcuity (CELC) reported Current Assets of $465.7 million for Q4 2025, up 90.4% on a YoY basis from $244.6 million in Q4 2024, and down 2.07% quarter-over-quarter from $475.5 million in Q3 2025.
Celcuity (CELC) Current Assets (2016 - 2025) Analysis & Trends
Celcuity has reported Current Assets for 10 years, with the latest figure at $465.7 million in Q4 2025.
- For the quarter ending Q4 2025, Current Assets rose 90.4% year-over-year to $465.7 million; the trailing twelve-month figure through Dec 2025 stood at $465.7 million (up 90.4% YoY), and the FY2025 full-year result was $465.7 million, up 90.4% from the prior year.
- Current Assets for Q4 2025 stood at $465.7 million, down from $475.5 million in the prior quarter.
- The five-year high for Current Assets was $475.5 million in Q3 2025, with the low at $35.7 million in Q1 2021.
- Historically, Current Assets has averaged $181.7 million across 5 years, with a median of $169.6 million in 2022.
- Annual changes were most pronounced in 2021 — Current Assets jumped 601.51% — and 2025, when it plunged 37.28%.
- Celcuity's Current Assets stood at $85.4 million in 2021, then soared by 105.26% to $175.2 million in 2022, then grew by 8.79% to $190.6 million in 2023, then grew by 28.32% to $244.6 million in 2024, then surged by 90.4% to $465.7 million in 2025.
- The last three Current Assets figures came in at $465.7 million (Q4 2025), $475.5 million (Q3 2025), and $183.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 600.85 Mn |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | 465.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 465.66 Mn |
| Sep 30, 2025 | 475.50 Mn |
| Jun 30, 2025 | 183.10 Mn |
| Mar 31, 2025 | 217.60 Mn |
| Dec 31, 2024 | 244.57 Mn |
| Sep 30, 2024 | 272.44 Mn |
| Jun 30, 2024 | 291.93 Mn |
| Mar 31, 2024 | 187.52 Mn |
| Dec 31, 2023 | 190.59 Mn |
| Sep 30, 2023 | 141.71 Mn |
| Jun 30, 2023 | 152.81 Mn |
| Mar 31, 2023 | 164.10 Mn |
| Dec 31, 2022 | 175.19 Mn |
| Sep 30, 2022 | 64.69 Mn |
| Jun 30, 2022 | 71.96 Mn |
| Mar 31, 2022 | 79.44 Mn |
| Dec 31, 2021 | 85.35 Mn |
| Sep 30, 2021 | 91.18 Mn |
| Jun 30, 2021 | 42.25 Mn |
| Mar 31, 2021 | 35.71 Mn |